Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
US Army
US Department of Justice
Covington
Cantor Fitzgerald
AstraZeneca
Boehringer Ingelheim
Harvard Business School
Dow
UBS

Generated: January 23, 2018

DrugPatentWatch Database Preview

ZOLOFT Drug Profile

« Back to Dashboard

When do Zoloft patents expire, and when can generic versions of Zoloft launch?

Zoloft is a drug marketed by Pfizer and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has fifty-two patent family members in forty-five countries.

The generic ingredient in ZOLOFT is sertraline hydrochloride. There are twenty-two drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the sertraline hydrochloride profile page.
Drug patent expirations by year for ZOLOFT
Pharmacology for ZOLOFT
Medical Subject Heading (MeSH) Categories for ZOLOFT

US Patents and Regulatory Information for ZOLOFT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer ZOLOFT sertraline hydrochloride CONCENTRATE;ORAL 020990-001 Dec 7, 1999 AA RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-004 Dec 30, 1991 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-001 Dec 30, 1991 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride CONCENTRATE;ORAL 020990-001 Dec 7, 1999 AA RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-005 Mar 6, 1996 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-003 Dec 30, 1991 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-002 Dec 30, 1991 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ZOLOFT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-004 Dec 30, 1991 ➤ Subscribe ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-002 Dec 30, 1991 ➤ Subscribe ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-005 Mar 6, 1996 ➤ Subscribe ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-001 Dec 30, 1991 ➤ Subscribe ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride CONCENTRATE;ORAL 020990-001 Dec 7, 1999 ➤ Subscribe ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-002 Dec 30, 1991 ➤ Subscribe ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-003 Dec 30, 1991 ➤ Subscribe ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-003 Dec 30, 1991 ➤ Subscribe ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-005 Mar 6, 1996 ➤ Subscribe ➤ Subscribe
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-004 Dec 30, 1991 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ZOLOFT
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Tablets 150 mg and 200 mg ➤ Subscribe 11/9/2005

International Patents for ZOLOFT

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
McKesson
Federal Trade Commission
Deloitte
Merck
Farmers Insurance
Cipla
Covington
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot